Biostatistics, Epidemiology & Environmental Health Sciences: Faculty Publications
Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials
Document Type
Article
Publication Date
4-20-2020
Publication Title
Abstract
Oncology drug discovery and proper conduct of cancer clinical trials are essential to our battle against cancer. According to a 2015 Center for Disease Control and Prevention (CDC) report, the expected cancer cases and deaths in 2020 are 1.9 million and 630,000. While the world is fighting COV-19 pandemic, it is also important to be more creative than ever to continue anti-cancer drug development in a safe manner - without exposing cancer patients to unnecessary COVID-19 risks while maintaining the integrity of cancer clinical trials.
Recommended Citation
Tirgan, Michael T., Qing Liu, Karl E. Peace.
2020.
"Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials."
LinkedIn.
source: Linkedin.com
https://digitalcommons.georgiasouthern.edu/bee-facpubs/161
Copyright
This work is archived and distributed under the repository's Standard Copyright and Reuse License (opens in new tab). End users may copy, store, and distribute this work without restriction. For all other uses, permission must be obtained from the copyright owners or their authorized agents.
